On the contrary, a prospective study has indicated that basal serum SHBG is negatively associated with NAFLD development but positively associated with NAFLD regression, suggesting a more complex role of SHBG in the pathogenesis of NAFLD and insulin resistance [90]. The gene discussed is SHBG; the disease is metabolic dysfunction-associated steatotic liver disease.